Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jennifer Lynne Bath Insider Profile
4 Followers
Jennifer Lynne Bath, President & Chief Executive Officer at ImmunoPrecise Antibodies, holds 248.82K shares in ImmunoPrecise Antibodies (Ticker: IPA). Most recently, Jennifer Lynne Bath Bought $9,000 shares of ImmunoPrecise Antibodies on Mar 28, 2024 for an estimated value of 13.89K.
Jennifer Lynne Bath ImmunoPrecise Antibodies (IPA)President & Chief Executive Officer
ImmunoPrecise Antibodies (IPA)
President & Chief Executive Officer
Ranked #91,173 out of 98,564 Corporate Insiders
Profitable Transactions
6 out of 52 Profitable Transactions
Average Return
-11.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jennifer Lynne Bath's holdings
Insider Roles
President & Chief Executive Officer
Roles that Jennifer Lynne Bath holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jan 21, 2020 - Jan 21, 2021
Return:+555.10%
The most profitable trade made by Jennifer Lynne Bath
Jennifer Lynne Bath's Trading History
List of latest transactions for each holding click on a transaction to see Jennifer Lynne Bath's performance on stock
You May Also Like
Jennifer Lynne Bath insider profile FAQ
What is the percentage of profitable transactions made by Jennifer Lynne Bath?
The percentage of profitable transactions made by Jennifer Lynne Bath is 12%.
What is the average return per transaction made by Jennifer Lynne Bath?
The average return per transaction made by Jennifer Lynne Bath is -11.80%.
What stocks does Jennifer Lynne Bath hold?
Jennifer Lynne Bath holds: IPA stocks.
What was Jennifer Lynne Bath’s latest transaction?
Jennifer Lynne Bath latest transaction was an Informative Buy of $13.89K.
What was Jennifer Lynne Bath's most profitable transaction?
Jennifer Lynne Bath’s most profitable transaction was an Informative Buy of IPA stock on January 21, 2020. The return on the trade was 555.10%.
What is Jennifer Lynne Bath's role in ImmunoPrecise Antibodies?
Jennifer Lynne Bath's role in ImmunoPrecise Antibodies is President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.